TrialBMC cancer2020

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.

Yvonne L E Ang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.